Latest News for: biotechnology

Edit

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire 03 Apr 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced that inducement awards were granted to staff hired in March, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4) ... .
Edit

Plant Biotechnology Market worth $76.79 billion by 2030 (Markets and Markets Limited)

Public Technologies 02 Apr 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 123415220) .
Edit

Biomednewsbreaks - Fifty 1 Labs Inc. (FITY), Genetic Networks Set To Push The Boundaries Of Biotechnology

MENA FN 02 Apr 2025
(MENAFN - Investor Brand Network) Fifty 1 Labs (OTC. FITY) , a forward-thinking leader in biotechnology and health innovation, today announced a groundbreaking achievement by its recently acquired ... .
Edit

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Nasdaq Globe Newswire 02 Apr 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sana To Contact Him Directly To Discuss Their Options ... .
Edit

Robbins LLP Reminds SANA Investors with Large Losses to Contact the Firm for Information About the Securities Fraud Class Action Against Sana Biotechnology, Inc.

PR Newswire 02 Apr 2025
SAN DIEGO, April 2, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Sana Biotechnology, Inc.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Lixte Biotechnology Holdings Inc)

Public Technologies 02 Apr 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... Washington, D.C ... OMB Number. 3235-0287 ... 0.5 ... LIXTE BIOTECHNOLOGY HOLDINGS, INC ... Lixte Biotechnology Holdings Inc.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Adverum Biotechnologies Inc)

Public Technologies 02 Apr 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... 2 ... Adverum Biotechnologies, Inc ... Adverum Biotechnologies Inc.
×